Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients

Publisher： Karger

E-ISSN： 1421-9670|44|1|71-80

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.44, Iss.1, 2016-07, pp. : 71-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Homa-IR: A Marker of Vascular Dysfunction in Nondiabetic Hemodialysis Patients?

By  

Blood Purification, Vol. 29, Iss. 4, 2010-02 ,pp. : 327-328

Karger

Access to resources Recommend Favorite

Hemodialysis Vascular Access Dysfunction: From Pathophysiology to Novel Therapies

By  

Blood Purification, Vol. 21, Iss. 1, 2003-01 ,pp. : 99-110

Karger

Access to resources Recommend Favorite

Novel Therapies for Hemodialysis Vascular Access Dysfunction: Fact or Fiction!

By  

Blood Purification, Vol. 23, Iss. 1, 2011-02 ,pp. : 29-35

Karger

Access to resources Recommend Favorite

Diastolic Dysfunction and High Levels of New Cardiac Biomarkers as Risk Factors for Cardiovascular Events and Mortality in Hemodialysis Patients

By  

Blood Purification, Vol. 36, Iss. 2, 2013-09 ,pp. : 98-106

Karger

Access to resources Recommend Favorite

Skin Autofluorescence: A Pronounced Marker of Mortality in Hemodialysis Patients

By  

Nephron Extra, Vol. 2, Iss. 1, 2012-07 ,pp. : 184-191

Karger

Access to resources Recommend Favorite